Analyzing over 40,000 #patients , this #realworldevidence (#RWE) study sheds light on the #ctdna shed and detected in various solid #tumours. Is it time to expand the role of #liquidbiopsy assays beyond the 9 #cancer types recommended by the NCCN guidelines ?
https://meetings.asco.org/abstracts-presentations/214579
Biomarker driven cancer management can potentially change the whole picture , when it comes to prognosis of cancer.
Click here for Cancer Care Advice
No comments:
Post a Comment